A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy

NCT07572812 · clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shanghai UniXell Biotechnology Co., Ltd

Collaborators